Companies / International Stem Cell CORP

International Stem Cell CORP

OTC: ISCOCIK 1355790SAN DIEGO, CA

Financials · FY2025

Revenue$9.10M
Net income$-418.0K
Total debt—
Cash$304.0K
Diluted EPS$-0.05
Shares outstanding8.0M

Ownership

8.0M shares outstanding · as of May 11, 2026
100.0%Public float
Ownership
Public float100.00%8,004,389

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Don WrightDirector
——
Maier Paul VDirector
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 11, 2026Don Wright
Director
GrantStock Option (Right to Buy)—+183K
182,584
2.28% of shares
low
Jun 11, 2026Don Wright
Director
GrantStock Option (Right to Buy)—+30K
30,000
0.37% of shares
low
Jun 11, 2026Maier Paul V
Director
GrantStock Option (Right to Buy)—+183K
182,584
2.28% of shares
low
Jun 11, 2026Maier Paul V
Director
GrantStock Option (Right to Buy)—+30K
30,000
0.37% of shares
low